Showing results (51-60 of 560) with videos related to

Sort By:
Pageof 56
Genome Medicine|June 28, 2012
Guanylate cyclase C signaling: an intestinal secretory pathway where bugs, genes and new drugs intersectMichael Camilleri
Gut|September 4, 2023
Abnormal gastrointestinal motility is a major factor in explaining symptoms and a potential therapeutic target in patients with disorders of gut-brain interactionMichael Camilleri
JAMA|July 22, 2026
Gastroparesis: A ReviewMichael Camilleri
Digestive Diseases (Basel, Switzerland)|June 23, 2016
Functional Dyspepsia and GastroparesisMichael Camilleri
The Journal of Physiology|November 24, 2024
Incretin impact on gastric function in obesity: physiology, and pharmacological, surgical and endoscopic treatmentsMichael Camilleri
Neurogastroenterology and Motility|August 28, 2023
The role of gastric function in control of food intake (and body weight) in relation to obesity, as well as pharmacological and surgical interventionsMichael Camilleri
Reviews in Gastroenterological Disorders|July 19, 2002
Advances in diabetic gastroparesisMichael Camilleri
Idrugs : the Investigational Drugs Journal|December 15, 2010
LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndromeMichael Camilleri
The American Journal of Gastroenterology|March 6, 2012
Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?Michael Camilleri
British Journal of Pharmacology|March 24, 2004
Treating irritable bowel syndrome: overview, perspective and future therapiesMichael Camilleri
Pageof 56